No Data
No Data
Oppenheimer Sticks to Its Buy Rating for Achieve Life Sciences (ACHV)
Achieve Life Sciences Reaches Milestone in Clinical Trial for Smoking Cessation Drug
JonesTrading Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $20
Achieve Life Sciences (ACHV) Gets a Buy From JonesTrading
Express News | Achieve Life Sciences Inc - on Track for Nda Submission in Q2 2025
Express News | Achieve Life Sciences Inc - No Safety Concerns Identified in Orca-Ol Trial
Unlock the Full List